Celldex Therapeutics Stock Price History
| CLDX Stock | USD 26.76 1.38 4.90% |
Below is the normalized historical share price chart for Celldex Therapeutics extending back to May 15, 1986. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Celldex Therapeutics stands at 26.76, as last reported on the 27th of November, with the highest price reaching 28.33 and the lowest price hitting 26.53 during the day.
If you're considering investing in Celldex Stock, it is important to understand the factors that can impact its price. Celldex Therapeutics secures Sharpe Ratio (or Efficiency) of -0.15, which signifies that the company had a -0.15% return per unit of risk over the last 3 months. Celldex Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Celldex Therapeutics' Mean Deviation of 2.76, standard deviation of 3.77, and Risk Adjusted Performance of (0.08) to double-check the risk estimate we provide.
At this time, Celldex Therapeutics' Total Stockholder Equity is fairly stable compared to the past year. Common Stock Shares Outstanding is likely to rise to about 50.9 M in 2024, whereas Capital Stock is likely to drop slightly above 40.1 K in 2024. . At this time, Celldex Therapeutics' Price To Sales Ratio is fairly stable compared to the past year. Price Sales Ratio is likely to rise to 293.12 in 2024, whereas Price Earnings Ratio is likely to drop (14.27) in 2024. Celldex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of March 2008 | 200 Day MA 36.772 | 50 Day MA 29.9178 | Beta 1.594 |
Celldex |
Sharpe Ratio = -0.1462
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CLDX |
Estimated Market Risk
| 3.78 actual daily | 33 67% of assets are more volatile |
Expected Return
| -0.55 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.15 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Celldex Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Celldex Therapeutics by adding Celldex Therapeutics to a well-diversified portfolio.
Price Book 2.3755 | Enterprise Value Ebitda (17.34) | Price Sales 177.9642 | Shares Float 66.2 M | Wall Street Target Price 67.1 |
Celldex Therapeutics Stock Price History Chart
There are several ways to analyze Celldex Stock price data. The simplest method is using a basic Celldex candlestick price chart, which shows Celldex Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | September 4, 2024 | 44.54 |
| Lowest Price | November 18, 2024 | 23.31 |
Celldex Therapeutics November 27, 2024 Stock Price Synopsis
Various analyses of Celldex Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Celldex Stock. It can be used to describe the percentage change in the price of Celldex Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Celldex Stock.| Celldex Therapeutics Price Rate Of Daily Change | 0.95 | |
| Celldex Therapeutics Price Action Indicator | (1.36) | |
| Celldex Therapeutics Price Daily Balance Of Power | (0.77) |
Celldex Therapeutics November 27, 2024 Stock Price Analysis
Celldex Stock Price History Data
The price series of Celldex Therapeutics for the period between Thu, Aug 29, 2024 and Wed, Nov 27, 2024 has a statistical range of 21.23 with a coefficient of variation of 20.36. The prices are distributed with arithmetic mean of 32.52. The median price for the last 90 days is 30.21. The company had 1:15 stock split on 11th of February 2019. Celldex Therapeutics issued dividends on 2019-02-11.| Open | High | Low | Close | Volume | ||
11/27/2024 | 27.89 | 28.33 | 26.53 | 26.76 | ||
| 11/26/2024 | 27.89 | 28.33 | 26.53 | 26.76 | 3,325,140 | |
| 11/25/2024 | 27.88 | 28.40 | 27.34 | 28.14 | 946,607 | |
| 11/22/2024 | 26.33 | 27.14 | 26.00 | 27.02 | 691,020 | |
| 11/21/2024 | 26.60 | 27.09 | 26.19 | 26.22 | 720,414 | |
| 11/20/2024 | 25.00 | 26.78 | 25.00 | 26.40 | 1,123,258 | |
| 11/19/2024 | 23.25 | 25.63 | 23.25 | 24.98 | 1,043,169 | |
| 11/18/2024 | 23.62 | 23.76 | 22.93 | 23.31 | 956,987 | |
| 11/15/2024 | 25.89 | 25.89 | 23.49 | 23.55 | 1,249,780 | |
| 11/14/2024 | 26.72 | 27.12 | 25.44 | 25.74 | 866,476 | |
| 11/13/2024 | 27.16 | 28.15 | 26.77 | 26.84 | 831,992 | |
| 11/12/2024 | 26.70 | 27.90 | 26.31 | 27.01 | 1,115,004 | |
| 11/11/2024 | 26.82 | 26.82 | 25.56 | 26.21 | 1,055,007 | |
| 11/08/2024 | 26.53 | 27.01 | 25.84 | 26.22 | 1,280,028 | |
| 11/07/2024 | 28.00 | 28.13 | 25.73 | 26.47 | 856,400 | |
| 11/06/2024 | 26.00 | 28.11 | 24.87 | 27.63 | 1,718,397 | |
| 11/05/2024 | 25.34 | 25.72 | 24.43 | 25.43 | 1,303,321 | |
| 11/04/2024 | 25.60 | 25.83 | 25.09 | 25.39 | 1,120,509 | |
| 11/01/2024 | 25.91 | 26.88 | 25.29 | 25.68 | 1,128,081 | |
| 10/31/2024 | 26.11 | 26.37 | 25.67 | 26.06 | 1,606,798 | |
| 10/30/2024 | 26.71 | 27.37 | 26.14 | 26.33 | 669,873 | |
| 10/29/2024 | 28.09 | 28.20 | 26.16 | 26.86 | 2,096,600 | |
| 10/28/2024 | 27.29 | 29.38 | 27.29 | 27.97 | 1,152,774 | |
| 10/25/2024 | 28.13 | 28.31 | 26.80 | 26.95 | 618,496 | |
| 10/24/2024 | 28.89 | 28.97 | 27.98 | 28.13 | 621,509 | |
| 10/23/2024 | 28.67 | 28.92 | 28.33 | 28.67 | 821,584 | |
| 10/22/2024 | 28.50 | 29.01 | 28.09 | 28.76 | 595,099 | |
| 10/21/2024 | 28.00 | 29.07 | 27.51 | 28.69 | 820,021 | |
| 10/18/2024 | 28.75 | 29.00 | 28.06 | 28.25 | 864,609 | |
| 10/17/2024 | 29.75 | 29.93 | 28.40 | 28.74 | 1,067,156 | |
| 10/16/2024 | 29.65 | 30.41 | 29.17 | 29.72 | 780,551 | |
| 10/15/2024 | 30.14 | 30.48 | 29.23 | 29.40 | 715,854 | |
| 10/14/2024 | 31.16 | 31.66 | 30.15 | 30.28 | 1,072,507 | |
| 10/11/2024 | 29.61 | 31.35 | 29.55 | 31.32 | 559,887 | |
| 10/10/2024 | 29.76 | 30.02 | 29.22 | 29.68 | 579,568 | |
| 10/09/2024 | 30.55 | 30.55 | 29.60 | 30.09 | 829,361 | |
| 10/08/2024 | 30.58 | 31.30 | 30.39 | 30.55 | 441,434 | |
| 10/07/2024 | 31.57 | 31.58 | 30.02 | 30.41 | 1,082,455 | |
| 10/04/2024 | 31.09 | 31.09 | 29.77 | 30.65 | 630,082 | |
| 10/03/2024 | 29.92 | 31.00 | 29.51 | 30.84 | 1,216,443 | |
| 10/02/2024 | 32.02 | 32.67 | 30.13 | 30.21 | 1,043,765 | |
| 10/01/2024 | 33.94 | 34.50 | 32.39 | 32.40 | 992,550 | |
| 09/30/2024 | 33.02 | 34.10 | 32.84 | 33.99 | 1,017,905 | |
| 09/27/2024 | 32.20 | 33.32 | 31.22 | 33.20 | 1,366,015 | |
| 09/26/2024 | 36.46 | 36.76 | 32.49 | 32.86 | 3,071,642 | |
| 09/25/2024 | 40.84 | 47.00 | 28.51 | 36.02 | 12,342,991 | |
| 09/24/2024 | 40.20 | 41.51 | 39.60 | 40.96 | 803,290 | |
| 09/23/2024 | 41.47 | 42.12 | 40.15 | 40.17 | 630,412 | |
| 09/20/2024 | 41.13 | 41.88 | 40.45 | 41.24 | 1,389,935 | |
| 09/19/2024 | 42.89 | 43.02 | 40.82 | 41.16 | 1,209,854 | |
| 09/18/2024 | 41.50 | 43.19 | 41.50 | 41.85 | 1,079,374 | |
| 09/17/2024 | 43.34 | 44.87 | 41.11 | 41.24 | 1,142,309 | |
| 09/16/2024 | 44.24 | 44.53 | 42.75 | 42.86 | 1,000,009 | |
| 09/13/2024 | 42.16 | 44.28 | 41.97 | 44.16 | 545,418 | |
| 09/12/2024 | 41.68 | 42.33 | 41.36 | 41.75 | 385,098 | |
| 09/11/2024 | 41.79 | 42.36 | 41.22 | 41.64 | 444,269 | |
| 09/10/2024 | 42.55 | 43.16 | 41.74 | 42.04 | 604,283 | |
| 09/09/2024 | 44.00 | 45.15 | 41.71 | 42.28 | 770,788 | |
| 09/06/2024 | 43.80 | 44.13 | 42.78 | 43.76 | 517,399 | |
| 09/05/2024 | 44.58 | 44.77 | 42.71 | 43.47 | 762,610 | |
| 09/04/2024 | 41.21 | 45.08 | 40.98 | 44.54 | 978,134 |
About Celldex Therapeutics Stock history
Celldex Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Celldex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Celldex Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Celldex Therapeutics stock prices may prove useful in developing a viable investing in Celldex Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 48.4 M | 50.9 M | |
| Net Loss | -101.1 M | -106.1 M |
Celldex Therapeutics Quarterly Net Working Capital |
|
Celldex Therapeutics Stock Technical Analysis
Celldex Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Manager Now
Portfolio ManagerState of the art Portfolio Manager to monitor and improve performance of your invested capital |
| All Next | Launch Module |
Celldex Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Celldex Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Celldex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Celldex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.08) | |||
| Jensen Alpha | (0.65) | |||
| Total Risk Alpha | (1.05) | |||
| Treynor Ratio | (0.29) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Celldex Stock Analysis
When running Celldex Therapeutics' price analysis, check to measure Celldex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celldex Therapeutics is operating at the current time. Most of Celldex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Celldex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celldex Therapeutics' price. Additionally, you may evaluate how the addition of Celldex Therapeutics to your portfolios can decrease your overall portfolio volatility.